Prof. Dr. MUSTAFA OKTAY TARHAN

Yayın Ağı

Makaleler 95

1. Brucella prosthetic valve endocarditis: A case study

DÖNGELLİ H., ÜNAL A., AYGÜN İ. E., ÖZPELİT E., TARHAN M. O.

Cor et Vasa , cilt.67, ss.7-11, 2025 (ESCI)

2. Addressing Hypercalcemia: A 3-Year Retrospective Analysis in a Tertiary Care Center

Serbetci N., Bayraktar F., Doruk O. G., ADIYAMAN S. C., TARHAN M. O.

Eastern Journal of Medicine , cilt.30, sa.4, ss.610-618, 2025 (Scopus, TRDizin)

3. An Infective Endocarditis Case Report Involving Both Native Aortic and Mitral Valves Due to Streptococcus Vestibularis

DÖNGELLİ H., KIZARTICI B., TARHAN M. O., ÖZPELİT E., SARIOSMANOĞLU O. N., Taşçı H. K.

Prague Medical Report , cilt.126, sa.1, ss.26-29, 2025 (Scopus) Sürdürülebilir Kalkınma

4. The prognostic role of survivin expression in breast cancer: A systematic review and meta-analysis

Bolat Kucukzeybek B., Kucukzeybek Y., Basbinar Y., Ellidokuz H., Tekindal M. A., Dinckal C., et al.

MEDICINE , cilt.103, sa.40, ss.1-2, 2024 (SCI-Expanded)

5. A Case Report of Synchronous Lung Adenocarcinoma and Systemic Mastocytosis

Tarhan M. O.

Scholars Journal of Medical Case Reports , ss.1-5, 2024 (Hakemli Dergi)

6. Case Report of Osler-Weber-Rendu Syndrome with Incidentally Detected Ipsilateral Renal Adnexal Agenesis

Tarhan M. O.

ARC Journal of Clinical Case Reports , cilt.10, sa.2, ss.9-15, 2024 (Hakemli Dergi)

7. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients

Uzum Y., Salman T., Oflazoglu U., Yildiz Y., Varol U., Aysin M., et al.

Bratislava Medical Journal , cilt.125, sa.8, ss.463-467, 2024 (SCI-Expanded)

8. Warthin tumour and IgG-₄-RD with pleural involvement: shared immunity or coincidence?

KARAKAYA B., Gulle S., Gurel D., SARIOĞLU S., Ozkal S., BİRLİK A. M., et al.

Scandinavian journal of rheumatology , cilt.51, sa.6, ss.522-524, 2022 (SCI-Expanded)

9. The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels

Oflazoglu U., Caglar S., Yilmaz H. E., Onal H. T., Varol U., Salman T., et al.

EUROPEAN GERIATRIC MEDICINE , cilt.13, sa.4, ss.795-803, 2022 (SCI-Expanded)

10. HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The Izmir oncology group (IZOG) study

Guc Z. G., Alacacioglu A., Kalender M. E., Oflazoglu U., Unal S., Yildiz Y., et al.

FRONTIERS IN NUTRITION , cilt.9, 2022 (SCI-Expanded)

11. Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients

Guc Z. G., Alacacioglu A., Yazir M. G., Kalender M. E., uenal S., Oflazoglu U., et al.

CHEMOTHERAPY , cilt.67, sa.1, ss.29-36, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study)

Oflazoglu U., ALACACIOĞLU A., Varol U., KÜÇÜKZEYBEK Y., Salman T., Onal H. T., et al.

SUPPORTIVE CARE IN CANCER , cilt.28, sa.8, ss.3965-3977, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) study

Oflazoglu U., ALACACIOĞLU A., Varol U., KÜÇÜKZEYBEK Y., Salman T., Taskaynatan H., et al.

SUPPORTIVE CARE IN CANCER , cilt.28, sa.6, ss.2899-2910, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

14. An analysis of adjuvant treatment strategies in operated pancreatic cancer patients: An Izmir oncology group study

Varol U., Uzum Y., Sengul A., Korkmaz U., Parvizi M., Akyol M., et al.

INDIAN JOURNAL OF CANCER , cilt.57, sa.2, ss.158-163, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Preliminary study of serum Galectin-1 in breast cancer carcinogenesis [Izmir Oncology Group (IZOG) study]

Cayir E. G., DEMİR L., Varol U., Atahan M. K., Salman T., Oflazoglu U., et al.

JOURNAL OF BUON , cilt.25, sa.2, ss.675-680, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Prognostic role of De Ritis and basal neutrophil to lymphocyte ratio in patients with advanced stage pancreatic cancer [Izmir Oncology Group (IZOG) Study]

Varol U., Kaya E., Oflazoglu U., Salman T., Yildiz Y., Taskaynatan H., et al.

JOURNAL OF BUON , cilt.25, sa.2, ss.1063-1069, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Prevalence and related factors of sarcopenia in newly diagnosed cancer patients

Oflazoglu U., ALACACIOĞLU A., Varol U., KÜÇÜKZEYBEK Y., Salman T., Taskaynatan H., et al.

SUPPORTIVE CARE IN CANCER , cilt.28, sa.2, ss.837-843, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Extremely rare cause of extrinsic compression of the stomach during esophagogastroduodenoscopy

Akin I., ALTAY C., BENGİ G., Tarhan O., SEÇİL M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.12, ss.1064-1065, 2019 (SCI-Expanded)

19. Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancer

Kucukzeybek B. B., BAYOĞLU İ. V., Kucukzeybek Y., Yıldız Y., Oflazoglu U., Atahan M. K., et al.

Polish Journal of Pathology , cilt.69, sa.2, ss.157-168, 2018 (SCI-Expanded)

20. Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer

Yildiz Y., Kucukzeybek Y., Alacacioglu A., Varol U., Yildiz I., Akyol M., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.38, sa.3, ss.444-448, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

21. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study

Cokmert S., TANRIVERDİ Ö., Karapolat I., Demir L., Bayoglu V., Can A., et al.

JOURNAL OF BUON , cilt.21, sa.6, ss.1410-1418, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor

Salman T., DEMİR L., Varol U., Akyol M., Oflazoglu U., Yildiz Y., et al.

JOURNAL OF BUON , cilt.21, sa.6, ss.1419-1424, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Leptin, insulin and body composition changes during adjuvant taxane based chemotherapy in patients with breast cancer, preliminary study

Alacacioglu A., Kebapcilar L., Gokgoz Z., Oztekin O., Bozkaya G., Tarhan O., et al.

INDIAN JOURNAL OF CANCER , cilt.53, sa.1, ss.39-42, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer

Bayoglu I. V., Yildiz I., Varol U., Cokmert S., Kucukzeybek Y., Alacacioglu A., et al.

Journal of B.U.ON. , cilt.20, sa.2, ss.460-467, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Dirican A., Kucukzeybek B. B., Alacacioglu A., Kucukzeybek Y., Erten C., Varol U., et al.

International Journal of Clinical Oncology , cilt.20, sa.1, ss.70-81, 2015 (SCI-Expanded)

26. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers

Bayoglu I. V., Kucukzeybek B. B., Kucukzeybek Y., Varol U., Yildiz I., Alacacioglu A., et al.

Biomedicine and Pharmacotherapy , cilt.70, sa.C, ss.190-195, 2015 (SCI-Expanded)

27. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: A single institutional retrospective study

BAYOĞLU İ. V., Yildiz I., Varol U., Cokmert S., Alacacioʇlu A., Kucukzeybek Y., et al.

Wspolczesna Onkologia , cilt.19, sa.5, ss.385-390, 2015 (Scopus)

28. Adjuvant chemotherapy and prognostic factors in stage II colon cancer - Izmir oncology group study

Kucukzeybek Y., Dirican A., Demir L., Yildirim S., Akyol M., Yildiz Y., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.6, ss.2413-2418, 2015 (Scopus)

29. STRATEGIES FOR INDEPTH INVOLVEMENT OF NATIONAL ACCREDIATIALING PROGRAMS IN CANCER CARE THE TURKISH EXPERIENCE

Turhal S., SAİP P. M., ŞAHİN B., Bozcuk H., Coskun S., Karabulut B., et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , cilt.10, ss.74, 2014 (SCI-Expanded)

30. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Kaplan M. A., Isikdogan A., Koca D., KÜÇÜKÖNER M., Gumusay O., Yildiz R., et al.

BREAST CANCER , cilt.21, sa.6, ss.677-683, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors

ALACACIOĞLU A., Ulger E., Varol U., YAVUZŞEN T., Akyol M., Yildiz Y., et al.

MEDICAL ONCOLOGY , cilt.31, sa.7, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer

Demir L., Ekinci N., Erten C., Somali I., Can A., Dirican A., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.109, sa.7, ss.665-675, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas Overin yüzey epitel karsinomlari{dotless}nda survivin ve MMP-9 ekspresyonlari{dotless}ni{dotless}n klinikopatolojik parametrelerle ve prognozla korelasyonu

Kuşku Çabuk F., Yiǧit S., Demir L., Çakalaǧaoǧlu F., TARHAN M. O.

Turk Patoloji Dergisi/Turkish Journal of Pathology , cilt.30, sa.1, ss.30-37, 2014 (Scopus)

34. Depression, Anxiety and Sexual Satisfaction in Breast Cancer Patients and their Partners-Izmir Oncology Group Study

ALACACIOĞLU A., Ulger E., Varol U., Yildiz I., Salman T., Bayoglu V., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.24, ss.10631-10636, 2014 (SCI-Expanded)

35. Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?

Dirican A., Varol U., KÜÇÜKZEYBEK Y., ALACACIOĞLU A., Erten C., Somali I., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.12, ss.4781-4786, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

36. Isolated Liver Metastasis of Sacrococcygeal Chordoma Case Report and Review of the Literature

AKYOL M., VAROL U., YILDIZ İ., BAYOĞLU İ. V., YILDIZ Y., DEMİR L., et al.

CASE REPORTS IN ONCOLOGICAL MEDICINE , cilt.2014, ss.1-3, 2014 (Hakemli Dergi)

37. Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype?

Demir L., Yigit S., Sadullahoglu C., Akyol M., Cokmert S., KÜÇÜKZEYBEK Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.22, ss.9739-9745, 2014 (SCI-Expanded)

38. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Cokmert S., Demir L., Can A., Akyol M., BAYOĞLU İ. V., Dirican A., et al.

Journal of B.U.ON. , cilt.19, sa.1, ss.75-82, 2014 (SCI-Expanded)

39. The prognostic significance of bone marrow metastases: Evaluation of 58 cases

Kucukzeybek B. B., Calli A. O., Kucukzeybek Y., Bener S., Dere Y., Dirican A., et al.

Indian Journal of Pathology and Microbiology , cilt.57, sa.3, ss.396-399, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

40. Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer

Bayoglu I. V., Varol U., Yildiz I., Muslu U., Alacacioglu A., Kucukzeybek Y., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.17, ss.7119-7123, 2014 (SCI-Expanded)

41. Cardiac rhabdomyosarcoma of the left atrium

Dirican A., Kucukzeybek Y., Erten C., Somali I., Can A., BAYOĞLU İ. V., et al.

Wspolczesna Onkologia , cilt.18, sa.1, ss.73-75, 2014 (Scopus)

42. Acute cardiotoxic effects of adjuvant trastuzumab treatment and its relation to oxidetive stress

Dirican A., Levent F., Alacacioglu A., Kucukzeybek Y., Varol U., Kocabas U., et al.

Angiology , cilt.65, sa.10, ss.951-952, 2014 (SCI-Expanded)

43. Skin and maxillary sinus involvement of colon cancer

Akyol M., Demir L., Dirican A., Ekinci N., Can A., Bayoglu V., et al.

Wspolczesna Onkologia , cilt.18, sa.1, ss.70-72, 2014 (Scopus)

44. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

Demir L., Yigit S., ELLİDOKUZ H., Erten C., Somali I., KÜÇÜKZEYBEK Y., et al.

CLINICAL & EXPERIMENTAL METASTASIS , cilt.30, sa.8, ss.1047-1062, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients

Can A., Alacacioglu A., Kucukzeybek Y., Erten C., Cokmert S., Demir L., et al.

Journal of B.U.ON. , cilt.18, sa.4, ss.845-850, 2013 (SCI-Expanded)

46. Depression and anxiety in cancer patients and their relatives.

Alacacioglu A., Tarhan O., Alacacioglu İ., Dirican A., Yilmaz U.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.18, sa.3, ss.767-74, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

47. The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer

Dirican A., Ekinci N., Avci A., Akyol M., Alacacioglu A., Kucukzeybek Y., et al.

Cancer Biomarkers , cilt.13, sa.1, ss.11-20, 2013 (SCI-Expanded)

48. Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors: Retrospective multicenter experience

Kefeli U., Buyukberber S., Akyol M., Yildiz R., Kaplan M. A., Ciltas A., et al.

Hepato-Gastroenterology , cilt.60, sa.124, ss.647-652, 2013 (SCI-Expanded)

49. Malignant Hemangiopericytoma Reports of Two Cases withDifferent Clinical Course and Review of the Literature

DEMİR L., ATASEVER REZANKO T., AKYOL M., BAYOĞLU İ. V., DİRİCAN A., CAN A., et al.

TÜRKİYE KLİNİKLERİ JOURNAL OF CASE REPORTS , cilt.21, sa.1, ss.18-23, 2013 (Hakemli Dergi)

50. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival

Tarhan M. O., Demir L., Somali I., Yigit S., Erten C., ALACACIOĞLU A., et al.

CLINICAL & EXPERIMENTAL METASTASIS , cilt.30, sa.2, ss.201-213, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: A case presentation and a brief review of the literature

Demir L., Can A., Oztop R., Dirican A., Bayoglu V., Akyol M., et al.

Journal of Cancer Research and Therapeutics , cilt.9, sa.1, ss.125-127, 2013 (SCI-Expanded)

52. Synchronous Appearance of a High-Grade Neuroendocrine Carcinoma of the Ampulla Vater and Sigmoid Colon Adenocarcinoma

Cokmert S., Demir L., Sari A. A., Kucukzeybek Y., Can A., Akyol M., et al.

CASE REPORTS IN ONCOLOGICAL MEDICINE , cilt.2013, 2013 (ESCI) Sürdürülebilir Kalkınma

53. Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?

Erten C., Demir L., Somali I., ALACACIOĞLU A., KÜÇÜKZEYBEK Y., Akyol M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.6, ss.3711-3717, 2013 (SCI-Expanded)

54. Does Immunohistochemistry Provide Additional Prognostic Data in Gastrointestinal Stromal Tumors?

Demir L., Ekinci N., Erten C., KÜÇÜKZEYBEK Y., ALACACIOĞLU A., Somali I., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.8, ss.4751-4758, 2013 (SCI-Expanded)

55. Clinicopathologic and Demographic Evaluation of Triple-Negative Breast Cancer Patients among a Turkish Patient Population: a Single Center Experience

Somali I., Ustaoglu B. Y., Tarhan M. O., Yigit S. C., Demir L., ELLİDOKUZ H., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.10, ss.6013-6017, 2013 (SCI-Expanded, Scopus)

56. One-day DCF regimen in patients with metastatic gastric cancer

Dirican A., Kucukzeybek Y., TARHAN M. O., Somali I., Erten C., Demir L., et al.

Tumori , cilt.99, sa.2, ss.145-148, 2013 (SCI-Expanded)

57. Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: Second line sunitinib treatment following IFN-alpha

Dirican A., Kucukzeybek Y., Erten C., Somali I., Demir L., Can A., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.3, ss.2101-2105, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results

TARHAN M. O., Gonel A., Kucukzeybek Y., Erten C., Cuhadar S., Yigit S. C., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.3, ss.1725-1729, 2013 (SCI-Expanded)

59. Cutaneous and subcutaneous metastases from bladder carcinoma

Dirican A., Küçükzeybek Y., Somali I., Erten Ç., Demir L., Can A., et al.

Wspolczesna Onkologia , cilt.16, sa.5, ss.451-452, 2012 (SCI-Expanded)

60. Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; Review of the literature

Demir L., Can A., Dirican A., Bayolu V., Rezanko T. A., Akyol M., et al.

Clinical Genitourinary Cancer , cilt.10, sa.4, ss.280-283, 2012 (SCI-Expanded)

61. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: Case report

Dirican A., Kucukzeybek Y., Somali I., Erten C., Demir L., Can A., et al.

European Journal of Gynaecological Oncology , cilt.33, sa.6, ss.652-655, 2012 (SCI-Expanded)

62. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy

Demir L., Erten C., Somali I., Can A., Dirican A., Bayoglu V., et al.

Journal of the Canadian Urological Association , cilt.6, sa.5, 2012 (SCI-Expanded)

63. Evaluation of endometrium by transvaginal ultrasonography and Doppler in tamoxifen-treated women with breast cancer

Bezircioglu I., Baloglu A., TARHAN M. O., Oziz E., Yigit S.

European Journal of Gynaecological Oncology , cilt.33, sa.3, ss.295-299, 2012 (SCI-Expanded)

64. Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature

Demir L., Erten C., Yigit S. C., Can A., Dirican A., Bayoglu V., et al.

Wspolczesna Onkologia , cilt.16, sa.2, ss.108-110, 2012 (SCI-Expanded)

65. Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.

ONCOLOGY , cilt.83, sa.3, ss.141-150, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

66. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma

Yigit S., Demir L., Tarhan M. O., Cabuk F. K., ELLİDOKUZ H., Erten C., et al.

NEOPLASMA , cilt.59, sa.5, ss.475-485, 2012 (SCI-Expanded, Scopus)

67. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer

Kucukzeybek Y., Dirican A., Erten C., Somali I., Can A., Demir L., et al.

Asian Pacific Journal of Cancer Prevention , cilt.13, sa.6, ss.2771-2774, 2012 (SCI-Expanded)

68. The association of complementary alternative medicine use with anxiety, depression and quality of life in Turkish cancer patients

Tarhan O., Alacacioglu A., Somali I., Sipahi H., ZENCİR M., Erten C., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.15, sa.5, ss.274-278, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

69. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer

Demir L., Somali I., Tarhan M. O., Erten C., ELLİDOKUZ H., Can A., et al.

JOURNAL OF BUON , cilt.16, sa.4, ss.682-688, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

70. Taxane-based adjuvant chemotherapy reduces endothelin-1 and symmetric dimethylarginine levels in patients with breast cancer

Alacacioglu A., Kebapcilar L., SARI İ., Gokgoz Z., Tarhan O., Somali I., et al.

JOURNAL OF BUON , cilt.15, sa.3, ss.572-576, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Gemcitabine plus infusional 5-fluorouracil and high dose leucovorin in advanced stage pancreatic cancer

Oztop İ., Alacacioglu A., ÜNEK İ. T., Tarhan O., Somali I., Cokmert S., et al.

JOURNAL OF BUON , cilt.15, sa.3, ss.462-469, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. An analysis of the use of complementary and alternative therapies in patients with breast cancer

TARHAN M. O., Muslu U., Somali I., Erten C., Alacacioglu A., Varol S., et al.

Breast Care , cilt.4, sa.5, ss.301-307, 2009 (SCI-Expanded)

73. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients

Somali I., Meydan N., Tarhan M. O., Oztop İ., Alacacioglu A., Yilmaz U.

JOURNAL OF BUON , cilt.14, sa.3, ss.429-433, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

74. Complementary-alternative medicine among cancer patients in the western region of Turkey

Tarhan O., Alacacioglu A., Somali I., Sipahi H., Zencir M., Oztop İ., et al.

JOURNAL OF BUON , cilt.14, sa.2, ss.265-269, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

75. Cisplatin plus Gemcitabine Chemotherapy in Taxane/Anthracycline-Resistant Metastatic Breast Cancer

Somali I., Alacacioglu A., Tarhan M. O., Meydan N., Erten C., Usalp S., et al.

CHEMOTHERAPY , cilt.55, sa.3, ss.155-160, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

76. Epidemiology and survival of hepatocellular carcinoma in Turkey: Outcome of multicenter study

Alacacioglu A., Somali I., Simsek I., Astarcioglu I., ÖZKAN M., Camci C., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.10, ss.683-688, 2008 (SCI-Expanded)

77. Synchronous appearance of male breast cancer and pancreatic cancer 15 years after the diagnosis of testicular cancer - report of a case

ÜNEK İ. T., Alacacioglu A., Tarhan O., Sevinc A. I., Oztop İ., Sagol Ö., et al.

JOURNAL OF BUON , cilt.13, sa.3, ss.421-424, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

78. Syndrome of inappropriate antidiuretic hormone secretion in a patient with advanced bladder cancer

Alacacioǧlu A., AKINCI B., Tarhan O., Gerçeker E., Başaran K., ÖZTOP İ., et al.

Turkish Journal of Cancer , cilt.37, sa.2, ss.69-71, 2007 (Scopus) Sürdürülebilir Kalkınma

79. Syndrome of inappropriate antidiuretic hormone secretion in a patient with advanced the cancer

ALACACIOĞLU A., AKINCI B., TARHAN M. O., GERÇEKER E., BAŞARAN K., ÖZTOP İ., et al.

TURKISH JOURNAL OF CANCER , cilt.37, sa.2, ss.69-71, 2007 (Scopus)

80. Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical HBV vaccination

Tarhan M. O., Aker A. I., Sipahi O. R., Kardes G., Biberoglu K.

MEDICAL SCIENCE MONITOR , cilt.12, sa.11, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

81. Irinotecan combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced gastric carcinoma as the first-line chemotherapy

Yilmaz U., Oztop İ., Alacacioglu A., Yaren A., Tarhan O., Somali I.

CHEMOTHERAPY , cilt.52, sa.5, ss.264-270, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

82. A patient with rectum cancer, and subcutaneous and pulmonary metastases

TARHAN M. O., Solmaz D., ÖZTOP İ., Tarhan O., Yaren A., Yassin S., et al.

BREATHE , cilt.2, sa.2, ss.179-182, 2005 (ESCI) Sürdürülebilir Kalkınma

83. Efficiency and tolerability of 5-fluorouracil-based adjuvant chemotherapy in elderly patients with colorectal carcinoma

ÖZTOP İ., Yaren A., Somali I., Tarhan O., Yilmaz U.

Turkish Journal of Cancer , cilt.34, sa.4, ss.139-145, 2004 (Scopus) Sürdürülebilir Kalkınma

84. Plasma tissue factor levels in patients with colon cancer receiving infusional 5-fluorouracil chemotherapy İnfüzyonel 5-fluorourasil kemoterapisi alan kolon kanserli hastalarda plazma doku faktörü düzeyleri

ÖZTOP İ., ATEŞ H., ALACACIOĞLU A., Yaren A., TARHAN M. O., Alakavuklar M., et al.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.14, sa.3, ss.147-152, 2004 (Scopus)

85. Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan

Oztop İ., Demirkan B., Yaren A., Tarhan O., Sengul B., Ulukus C., et al.

TUMORI , cilt.90, sa.5, ss.514-516, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

86. İnfüzyonel 5 Fluorourasil kemoterapisi Alan Kolon Kanserli Hastalarda Plazma Doku Faktörleri Düzeyleri

Öztop İ., Ateş H., Alacacıoğlu A., Yaren A., Tarhan M. O., Alakavuklar M., et al.

TÜRK HEMATOLOJİ-ONKOLOJİ DERGİSİ , cilt.14, sa.3, ss.147-152, 2004 (Hakemli Dergi) Sürdürülebilir Kalkınma

87. Central venous access system complications in patients with solid tumors Kanserli hastalarda uzun süreli kalici santral venöz kateter komplikasyonlari

ÖZTOP İ., YAVUZŞEN T., Yilmaz U., ÇAVDAR C., Yaren A., Tarhan O., et al.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.14, sa.2, ss.90-95, 2004 (Scopus)

88. Kanserli Hastalarda Uzun Süreli Kalıcı Santral Venöz Kateter Komplikasyonları

ÖZTOP İ., YAVUZŞEN T., YILMAZ A. U., ÇAVDAR C., YAREN A., TARHAN M. O., et al.

TÜRK HEMATOLOJİ-ONKOLOJİ DERGİSİ , cilt.14, sa.2, ss.90-95, 2004 (Scopus)

89. Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas

Oztop İ., Yilmaz U., YAVUZŞEN T., Yaren A., Tarhan O., Sagol Ö., et al.

CHEMOTHERAPY , cilt.50, sa.3, ss.127-132, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

90. The efficiency and tolerability of 5 Fluorouracil based adjuvant chemotherapy in elderly patients with colorectal cancer A ten years experience of a single institute

ÖZTOP İ., YAREN A., SOMALI I., TARHAN M. O., ALAKAVUKLAR M., YILMAZ A. U.

TURKISH JOURNAL OF CANCER , cilt.34, ss.4139-4145, 2004 (Hakemli Dergi)

91. The use of complementary alternative medicine among cancer patients in the western region of Turkey

Tarhan O., Alacacioglu A., ZENCİR M., ÖZTOP İ.

ANNALS OF ONCOLOGY , cilt.15, ss.214, 2004 (SCI-Expanded)

92. The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition

Oztop İ., Demirkan B., Tarhan O., Kayahan H., Yilmaz U., Kargi A., et al.

TUMORI JOURNAL , cilt.90, sa.1, ss.132-135, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

93. Nedeni Bilinmeyen Ateş Yeni Tanımlar ve Ülkemiz Koşullarında Yaklaşım

PEHLİVAN M., TARHAN M. O., BİBEROĞLU K.

TÜRKİYE TIP DERGİSİ , cilt.5, sa.2, ss.114-122, 1998 (Hakemli Dergi)

94. Trimethoprim/sulfamethoxazole-induced hypoglycemia in a malnourished patient with severe infection

Hekimsoy Z., Biberoglu S., Comlekci A., Tarhan O., Mermut C., Biberoglu K.

EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.136, sa.3, ss.304-306, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

95. ALKYLGLYCIDIC ACIDS - POTENTIAL NEW HYPOGLYCEMIC AGENTS

HO W., TUTWILER G., COTTRELL S., MORGANS D., TARHAN O., MOHRBACHER R.

JOURNAL OF MEDICINAL CHEMISTRY , cilt.29, sa.11, ss.2184-2190, 1986 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 64

1. İNTESTİNAL OBSTRÜKSİYON VE YAYGIN ÖDEME NEDEN OLAN JEJUNAL DİVERTİKÜLOZİS OLGUSU

ÜNSAL Ö., ÇOBAN M. M., TARHAN M. O., DERİCİ Z. S., AKPINAR H.

24.ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 19 - 23 Ekim 2022, (Tam Metin Bildiri)

2. NEDENİ BİLİN(E)MEYEN ATEŞ İLE PREZENTE OLAN KÜÇÜK LENFOSİTİK LENFOMA: OLGU SUNUMU

ÇOBAN M. M., ÜNSAL Ö., TARHAN M. O., ÖMEROĞLU ŞİMŞEK G., ÖZCAN M. A.

24.ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 19 Ekim 2022, (Tam Metin Bildiri)

3. A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer

Oflazoglu U., Varol U., Alacacioglu A., Salman T., Kucukzeybek Y., Taskaynatan H., et al.

43rd ESMO Congress (ESMO), Munich, Almanya, 19 - 23 Ekim 2018, cilt.29, ss.610, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Nötrofil lenfosit oranı ve platelet lenfosit oranının nöroendokrin tümörlerde prognostik önemi

SALMAN T., KAZAZ S., VAROL U., OFLAZOĞLU U., ÜNEK İ. T., KÜÇÜKZEYBEK Y., et al.

8.Gastrointestinal Onkoloji Kongresi, Türkiye, 8 - 09 Nisan 2016

5. OVER KANSERİ TANILI HASTALARDA ERCC1 C8092A POLİMORFİZMİ

KÜÇÜKZEYBEK Y., BASKIN Y., YİĞİT S., UYSAL T., BOLAT KÜÇÜKZEYBEK B., ALACACIOĞLU A., et al.

İZMİR ONKOLOJİ GÜNLERİ NADİR TÜMÖRLER SEMPOZYUMU, Türkiye, 26 - 28 Şubat 2016

6. NÖTROFİL LENFOSİT ORANI NLR TROMBOSİT LENFOSİT ORANI PLR VE ORTALAMA TROMBOSİT HACMİNİN MPV KOLOREKTAL KARSİNOMLU HASTALARDAKİ PROGNOSTİK VE PREDİKTİF DEĞERİ

OFLAZOĞLU U., SALMAN T., ALACACIOĞLU A., ÖNCÜ M., VAROL U., SEMİZ H. S., et al.

İZMİR ONKOLOJİ GÜNLERİ NADİR TÜMÖRLER SEMPOZYUMU, Türkiye, 26 - 28 Şubat 2016

7. ADJUVAN ENDOKRİN TEDAVİ ALAN ERKEN EVRE MEME KANSERLİ HASTALARDA VÜCUT KOMPOZİSYONU GLUKOLİPİD VE SERUM FGF 21 DÜZEYLERİNDEKİ DEĞİŞİKLER

AKYOL M., ALACACIOĞLU A., DEMİR L., KÜÇÜKZEYBEK Y., YILDIZ Y., GÜMÜŞ Z., et al.

İZMİR ONKOLOJİ GÜNLERİ NADİR TÜMÖRLER SEMPOZYUMU, Türkiye, 26 - 28 Şubat 2016

8. NÜKS LOKAL İLERİ EPİTELYAL OVER KANSERLİ HASTALARDA SERUM OMENTİN 1 DÜZEYİNİN DEĞERLENDİRİLMESİ İZOG ÇALIŞMASI

YILDIZ Y., YILDIZ İ., ALACACIOĞLU A., VAROL U., DEMİR L., KÜÇÜKZEYBEK Y., et al.

İZMİR ONKOLOJİ GÜNLERİ NADİR TÜMÖRLER SEMPOZYUMU, Türkiye, 26 - 28 Şubat 2016

9. GASTROİNTESTİNAL STROMAL TÜMÖRLERDE NÖTROFİLLENFOSİT VE PLATELETLENFOSİT ORANININ PROGNOSTİK ÖNEMİ

ÜZGEÇ GÜLLER P., YILDIZ Y., TAŞKAYNATAN H., KURTEL KOÇHAN G., ERSİL SOYSAL D., SALMAN T., et al.

İZMİR ONKOLOJİ GÜNLERİ NADİR TÜMÖRLER SEMPOZYUMU, Türkiye, 26 - 28 Şubat 2016

10. LEPTIN INSULIN AND BODY COMPOSITION CHANGES DURING ADJUVANT TAXANE BASED CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER

ALACACIOĞLU A., KEBAPCILAR L., GÖKGÖZ Z., TARHAN M. O.

İZMİR ONKOLOJİ GÜNLERİ NADİR TÜMÖRLER SEMPOZYUMU, Türkiye, 26 - 28 Şubat 2016

11. The effects of adjuvant endocrine treatment on the serum leptin, adiponectin and body composition in patients with breast cancer [Izmir Oncology Group(IZOG) Study]

Akyol M., DEMİR L., Alacacioglu A., Ellidiokuz H., Kucukzeybekl Y., Yildiz Y., et al.

European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Results of observational study to determine K ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey TURKRAS Study

GÜMÜŞ M., DANE F., KARABULUT B., UYGUN K., AYDIN K., ORHAN B., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015

13. Dokuz Eylül Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Bilim dalı tarafından intravenöz port yerleştirilen olguların retrospektif değerlendirilmesi

SALMAN T., TÜRKYILMAZ D., KOCA D., ÜNEK İ. T., ÜNAL O., AKMAN T., et al.

21. Ulusal Kanser Kongresi,2015., Türkiye, 22 - 26 Nisan 2015

14. İnsan Prostat Kanseri Hücre Hatlarında Thymoquinone Zoledronik Asit Kombinasyonunun Sitotoksik Ve Apoptotik Etkilerinin Araştırılması Ulusal Tıbbi Onkoloji Kongresi 2014

DİRİCAN A., ERTEN Ç., ATMACA H., BOZKURT E., KÜÇÜKZEYBEK Y., VAROL U., et al.

Ulusal Tıbbi Onkoloji Kongresi, 2014, Türkiye, 19 - 23 Mart 2014 Sürdürülebilir Kalkınma